|
Indianapolis, Ind. November 17, 2004
Frost & Sullivan Names Roche Diagnostics
Clinical Diagnostics Company of the Year
Company Receives Best in Industry Award
for the Third Successive Year
Frost & Sullivan, the international market consulting and intelligence
firm, presented Roche Diagnostics Corporation with the Clinical
Diagnostics Company of the Year Award at last week's 2004 Global
Excellence in Healthcare & Life Sciences Awards Banquet.
"Roche Diagnostics' innovation and effective cultivation of
customer awareness has generated strong products and high consumer
loyalty. It is through this innovation and dedication to its customers
that has helped Roche Diagnostics maintain solid growth," said
Manoj Kenkare, Vice President - Global research, Healthcare &
Life Sciences for Frost & Sullivan. "Roche Diagnostics'
dedication to improving people's quality of life globally is certainly
visible in its products and services. By keeping its focus on innovation
and its commitment to its customers, Roche Diagnostics has maintained
its leadership position in clinical diagnostics."
Frost & Sullivan presents the Clinical Diagnostics Company
of the Year Award each year to the company that has achieved comprehensive
excellence due to several factors. Roche Diagnostics demonstrated
excellence in executing marketing strategies, revenue growth, new
market penetration, marketing, promotion, and visibility of the
company.
"Roche Diagnostics is committed to innovating health information
and focusing on our customers. We are honored to receive this award
from Frost & Sullivan as a result of our strength in these areas,"
said Dick Aderman, Senior Vice President and General Manager, Roche
Centralized and Molecular Diagnostics, Roche Diagnostics.
Held in Naples, Fla., the Frost & Sullivan banquet honored
world-class companies for outstanding performance and achievements
in the healthcare industry. An annual event, the banquet recognizes
the quality and merit of these distinguished companies.
About Roche and the Roche Diagnostics
Division
Headquartered in Basel, Switzerland, Roche is one of the world's
leading research-intensive healthcare groups. Its core businesses
are pharmaceuticals and diagnostics. As a supplier of innovative
products and services for the prevention, diagnosis and treatment
of disease, the Group contributes on a broad range of fronts to
improving people's health and quality of life. Roche is number one
in the global diagnostics market, the leading supplier of medicines
for cancer and transplantation and a market leader in virology.
In 2003, the Pharmaceuticals Division generated 19.8 billion Swiss
francs in prescription drug sales, while the Diagnostics Division
posted sales of 7.4 billion Swiss francs. Roche employs roughly
65,000 people in 150 countries and has R&D agreements and strategic
alliances with numerous partners, including majority ownership interests
in Genentech and Chugai.
Roche's Diagnostics Division, the world leader in in-vitro diagnostics
with a uniquely broad product portfolio, supplies a wide array of
innovative testing products and services to researchers, physicians,
patients, hospitals and laboratories world-wide. Roche Diagnostics'
North American headquarters are located in Indianapolis, Ind. (www.roche-diagnostics.us).
For further information, please visit www.roche.com
and www.roche-diagnostics.com.
For additional information contact:
Lori LeRoy
Roche Diagnostics
Tel.: +1-317-521-7159
e-mail: lori.leroy@roche.com
www.roche-diagnostics.us
|
